Tech Transfer eNews Blog

U of Birmingham and Chinese institute join forces to advance TB treatments

By Jesse Schwartz
Published: October 30th, 2019

Researchers at the University of Birmingham (UB) in Great Britain are partnering with scientists from the Guangzhou Institutes of Biomedicine and Health (GIBH) in China to develop new treatments for tuberculosis (TB).

The goal of the research project is make effective drugs available to TB patients, especially those with drug-resistant strains of the disease. The teams in Britain and China have harnessed innovative, secure data sharing technology developed at UB to help them collaborate more efficiently on developing the anti-TB drugs.

“We developed a number of compounds that have great promise as therapeutic treatments,” says professor John S. Fossey, head of the drug discovery effort at UB. “Working online has been essential for us, allowing us smoothly to share project data across borders [and] contributing greatly to the success and sustainability of our partnership.”

James Wilkie, CEO of the university’s tech transfer arm UB Enterprise, comments, “This is the first jointly owned patent we’ve filed with a Chinese institution, and we’ve been delighted with the smoothness of the collaboration to date, and with the progressing development on compounds that could help fight disease and improve health for millions of people.”

Legion Pharma, a spinout from GIBH, will advance the research project’s most promising drug candidates to the marketplace.

Dr Luke Alderwick, director of the University of Birmingham Drug Discovery Facility, said our cutting-edge screening technology has enabled multidisciplinary collaboration between Biosciences and Chemistry that now reaches out to our partners in China. This project perfectly exemplifies how research teams can work effectively across borders and is a trail-blazer for future drug discovery initiatives that will follow.”

Source: Science| Business

International Collaborations and IP Protection is a three-session distance learning collection that will help you tap into growing international opportunities for sponsored research deals and other partnerships while also ensuring key issues surrounding IP and other contract terms are appropriately addressed. CLICK HERE for details.

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment